No Data
No Data
GoodRx Tumbles 21% Following Guidance Adjustments, Quarterly EPS Miss
GoodRx (GDRX) Reports Q2 Earnings: What Key Metrics Have to Say
GoodRx's Q2 Adjusted EPS, Revenue Rise; Issues Q3 Outlook; Sees FY Revenue Guidance at Low End of Range
GoodRx Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Adjusted EPS Results and Issued Q3 Revenue Guidance Below Estimates.
GoodRx Shares Rise 4.5% as Q2 Revenue Tops Estimates
Express News | GoodRx Holdings Shares Down 2.9% Premarket After Q2 Net Income Miss
No Data
Tan Chin Seng klang : must buy more apples and Nvidia